Most Clicked StoriesMore >


Hospitals object to distribution change for cancer drugs

PCMA SmartBrief | Oct 28, 2014

U.S. hospitals are criticizing Genentech for a distribution change that increases their costs for three cancer drugs. Rituxan, Herceptin and Avastin must be purchased through specialty distributors rather than general-line wholesalers. Time.com (10/27)


Independent pharmacy magazine editor gives nod to analysis on pharmacy participation in networks

PCMA SmartBrief | Oct 27, 2014

Novartis has high hopes for heart drug

PCMA SmartBrief | Oct 28, 2014

Forum on drug prices points the way toward larger conversation

PCMA SmartBrief | Oct 28, 2014

NCPA touts pharmacy "Lock-In" program in Medicare Part D to reduce prescription drug fraud and abuse

PCMA SmartBrief | Oct 29, 2014

Is a diabetes drug price war looming?

PCMA SmartBrief | Oct 29, 2014

Opinion: How high prices distort the search for new drugs

PCMA SmartBrief | Oct 24, 2014

Low-response-rate drugs put spotlight on low FDA approval standard

PCMA SmartBrief | Oct 27, 2014

CMS won't enforce some transparency rules for insurers this year

PCMA SmartBrief | Oct 27, 2014

Small businesses in 5 states get sneak peek at SHOP exchanges

PCMA SmartBrief | Oct 28, 2014


Find PCMA SmartBrief Issues by Date:





Sign up for PCMA SmartBrief



Designed specifically for PBM industry professionals, PCMA SmartBrief is a FREE, daily e-mail newsletter. It provides the the most relevant and actionable PBM industry news in a quick, easy to read format. Learn more